Bayer Group
Consolidated Statements of Cash Flows

 

 

 

 

 

 

 

 

 

3rd Quarter 2014

3rd Quarter 2015

 

First Nine Months 2014

First Nine Months 2015

 

 

€ million

€ million

 

€ million

€ million

Income from continuing operations after income taxes

 

808

989

 

3,125

3,437

Income taxes

 

236

296

 

1,087

1,064

Financial result

 

302

280

 

634

841

Income taxes paid or accrued

 

(350)

(684)

 

(1,285)

(1,757)

Depreciation, amortization and impairments

 

677

760

 

2,022

2,376

Change in pension provisions

 

(115)

(151)

 

(300)

(274)

(Gains) losses on retirements of noncurrent assets

 

(92)

(63)

 

(134)

(76)

Gross cash flow

 

1,466

1,427

 

5,149

5,611

 

 

 

 

 

 

 

Decrease (increase) in inventories

 

(245)

(276)

 

(557)

(427)

Decrease (increase) in trade accounts receivable

 

531

789

 

(1,176)

(1,253)

(Decrease) increase in trade accounts payable

 

210

(23)

 

(174)

(370)

Changes in other working capital, other non-cash items

 

(181)

389

 

252

1,372

Net cash provided by (used in) operating activities (net cash flow), continuing operations

 

1,781

2,306

 

3,494

4,933

Net cash provided by (used in) operating activities (net cash flow), discontinued operations

 

35

24

 

86

80

Net cash provided by (used in) operating activities (net cash flow) (total)

 

1,816

2,330

 

3,580

5,013

 

 

 

 

 

 

 

Cash outflows for additions to property, plant, equipment and intangible assets

 

(546)

(655)

 

(1,432)

(1,601)

Cash inflows from the sale of property, plant, equipment and other assets

 

30

81

 

81

165

Cash inflows from divestitures

 

297

2

 

303

2

Cash inflows from (outflows for) noncurrent financial assets

 

84

258

 

18

(78)

Cash outflows for acquisitions less acquired cash

 

(14)

(162)

 

(1,871)

(159)

Interest and dividends received

 

45

21

 

94

89

Cash inflows from (outflows for) current financial assets

 

(3,870)

(510)

 

(3,864)

(506)

Net cash provided by (used in) investing activities (total)

 

(3,974)

(965)

 

(6,671)

(2,088)

 

 

 

 

 

 

 

Dividend payments and withholding tax on dividends

 

(1)

(3)

 

(1,738)

(1,869)

Issuances of debt

 

4,965

4,445

 

11,798

11,647

Retirements of debt

 

(2,386)

(6,383)

 

(6,846)

(11,559)

Interest paid including interest-rate swaps

 

(227)

(284)

 

(393)

(571)

Interest received from interest-rate swaps

 

82

63

 

125

114

Cash outflows for the purchase of additional interests in subsidiaries

 

 

(1)

Net cash provided by (used in) financing activities (total)

 

2,433

(2,162)

 

2,945

(2,238)

 

 

 

 

 

 

 

Change in cash and cash equivalents due to business activities (total)

 

275

(797)

 

(146)

687

 

 

 

 

 

 

 

Cash and cash equivalents at beginning of period

 

1,228

3,247

 

1,662

1,853

 

 

 

 

 

 

 

Change in cash and cash equivalents due to changes in scope of consolidation

 

2

 

5

Change in cash and cash equivalents due to exchange rate movements

 

177

(57)

 

164

(150)

 

 

 

 

 

 

 

Cash and cash equivalents at end of period

 

1,680

2,395

 

1,680

2,395